Human Papillomavirus HPV
Human Papillomavirus, otherwise known as HPV, is a virus which infects the skin and moist membranes which line parts of the body. Most women have HPV and in the majority of cases it disappears, resulting in no damage to the body.There are over 100 HPV viruses. Some types of HPV can increase the risk of cervical cancer, particularly types 16,81,31,33 and 45. Almost all women with cervical cancer have at least one of these types of HPV in the cells of their cervix. Of these high risk types, HPV 16 and 18 constitute 70% of all cervical cancers. If one has a high risk type HPV this does not necessarily mean these will develop into cervical cancer; it must be remembered that other factors may influence the development of cervical cancer, for example the strength of one’s immune system.
HPVs can be transmitted through intimate contact with an affected person, including sexual intercourse and genital HPV is also spread through intimate contact.
At HealthHarmonie we use Cervarix and Gardasil HPV vaccines that:
- Can prevent infection from the most common types of HPV
- Is effective against types 16 and 18, these types are responsible for 72% of cervical cancer cases
- Is not effective against all types of HPV, therefore, it is important to attend for cervical screening regardless of vaccination
- Gardasil protects against HPV types 6 and 11, responsible for genital warts
Vaccination with an HPV vaccine should induce the host immune system to produce neutralising antibodies to the target virus. Ideally, it should be given before sexual activity has commenced. Therefore, it is recommended for girls between the ages of 11 to 13 but can commence in girls as early as 9. However, it can be given with effect to those of any age who already are sexually active.
Routine HPV vaccination will be introduced in the UK from September 2008, for girls aged 12-13, as part of the national immunisation programme. There will also be a two year catch up campaign, due to start in autumn 2009, which will include all girls who are up to 18 years of age, but not including those who are aged 18.
The vaccine is safe – it has been given to more than 70,000 women worldwide. In extensive trials 100% of vaccinated women developed immunity against the HPV types given within the vaccination type.
The vaccine is given by injection into the muscle. Three injections are needed, after the initial injection they are given at intervals of 2 month and 6 months.
Here are some links for further information on the HPV vaccine:
Following your consultation you will receive a written report. We will also ask if you would like a copy of the report sent to your NHS healthcare provider.
A HPV consultation is priced at £50, and a HPV Vaccination (three injections) including consultation is £450.
We welcome self fund patients and we are recognised by private health insurance companies (individual’s level of cover does vary, please check with your provider).
Please note that you do not need a GP referral.
Call 0121 454 7779 for further information or to make an appointment